ADAR and cancer: This result could be explained as breast cancer has a higher ADAR1 expression, leading to more RE sites than other cancer types (20) (Figure 2A) (Wilcoxon rank sum test p < 0.05 for all, Table S5B), leading to a higher burden of coding RE sites.